SCHEMBL9924457

SCHEMBL9924457

O=C(/N=C(/Nc1cc(F)cc(Cl)c1)N[C@H]1CC[C@H](NC(=O)c2ccccc2)CC1)c1ccc(F)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GRM5 P41594 2/20 0.41
MCHR1 Q99705 5/20 0.40
HTR2B P41595 2/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA1A P35348 1/20 0.40
HRH1 P35367 1/20 0.40
NPY5R Q15761 1/20 0.40
DPP4 P27487 1/20 0.40
KCNH2 Q12809 1/20 0.40
DPP7 Q9UHL4 1/20 0.40
CRHR1 P34998 1/20 0.40
SLC6A12 P48065 1/20 0.39
TMEM97 Q5BJF2 1/20 0.39
SIGMAR1 Q99720 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924333 0.93 NPC1 (0.44) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL9924083 0.92 NPC1 (0.44) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL9924071 0.90 KMT2A (0.43) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL9924169 0.90 CRHR1 (0.49) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL17206714 0.89 GRM5 (0.44) RAB9AMEN1KMT2AGRM5AR
SCHEMBL9924079 0.89 GRM4 (0.43) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL17206713 0.88 CES1 (0.44) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL17206620 0.88 GRM4 (0.39) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL17206699 0.87 GRM4 (0.39) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL17206721 0.87 MEN1 (0.39) NPC1RAB9AMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed